PEPG
Price
$1.17
Change
+$0.04 (+3.54%)
Updated
Apr 10 closing price
Capitalization
38.25M
62 days until earnings call
SLDB
Price
$2.63
Change
-$0.04 (-1.50%)
Updated
Apr 11, 11:45 AM (EDT)
Capitalization
206.91M
Ad is loading...

PEPG vs SLDB

Header iconPEPG vs SLDB Comparison
Open Charts PEPG vs SLDBBanner chart's image
PepGen
Price$1.17
Change+$0.04 (+3.54%)
Volume$162.9K
Capitalization38.25M
Solid Biosciences
Price$2.63
Change-$0.04 (-1.50%)
Volume$300
Capitalization206.91M
PEPG vs SLDB Comparison Chart
Loading...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PEPG vs. SLDB commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEPG is a Hold and SLDB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 11, 2025
Stock price -- (PEPG: $1.17 vs. SLDB: $2.67)
Brand notoriety: PEPG and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PEPG: 4% vs. SLDB: 26%
Market capitalization -- PEPG: $38.25M vs. SLDB: $206.91M
PEPG [@Biotechnology] is valued at $38.25M. SLDB’s [@Biotechnology] market capitalization is $206.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $263.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PEPG’s FA Score shows that 1 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • PEPG’s FA Score: 1 green, 4 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than PEPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PEPG’s TA Score shows that 4 TA indicator(s) are bullish while SLDB’s TA Score has 4 bullish TA indicator(s).

  • PEPG’s TA Score: 4 bullish, 6 bearish.
  • SLDB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both PEPG and SLDB are a bad buy in the short-term.

Price Growth

PEPG (@Biotechnology) experienced а -6.77% price change this week, while SLDB (@Biotechnology) price change was -21.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.29%. For the same industry, the average monthly price growth was -15.11%, and the average quarterly price growth was -17.07%.

Reported Earning Dates

PEPG is expected to report earnings on Aug 07, 2025.

SLDB is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+2.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLDB($207M) has a higher market cap than PEPG($38.3M). SLDB YTD gains are higher at: -33.250 vs. PEPG (-69.129). PEPG has higher annual earnings (EBITDA): -92.49M vs. SLDB (-121.9M). SLDB has more cash in the bank: 149M vs. PEPG (120M). PEPG has less debt than SLDB: PEPG (18.7M) vs SLDB (24.2M). PEPG (0) and SLDB (0) have equivalent revenues.
PEPGSLDBPEPG / SLDB
Capitalization38.3M207M19%
EBITDA-92.49M-121.9M76%
Gain YTD-69.129-33.250208%
P/E RatioN/AN/A-
Revenue00-
Total Cash120M149M81%
Total Debt18.7M24.2M77%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PEPGSLDB
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend about 1 month ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DXCM67.300.46
+0.69%
DexCom
APLT0.32N/A
+0.32%
Applied Therapeutics
HBCP42.17-1.73
-3.94%
Home Bancorp
AMPL9.01-0.59
-6.15%
Amplitude
NVMI177.98-13.75
-7.17%
Nova Ltd

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with SLDB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
+3.54%
SLDB - PEPG
34%
Loosely correlated
-2.55%
IMTX - PEPG
30%
Poorly correlated
-1.73%
DNLI - PEPG
29%
Poorly correlated
-2.80%
INZY - PEPG
28%
Poorly correlated
-2.78%
GRI - PEPG
28%
Poorly correlated
-6.92%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with PRME. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-2.55%
PRME - SLDB
44%
Loosely correlated
-6.40%
EDIT - SLDB
43%
Loosely correlated
-3.48%
KRYS - SLDB
43%
Loosely correlated
-4.47%
BEAM - SLDB
43%
Loosely correlated
-10.63%
ALLO - SLDB
43%
Loosely correlated
-3.52%
More